Neuropsychological symptoms and subclinical disease activity in multiple sclerosis patients receiving high-efficacy therapy.

Mühlenbrock P, Winter P, Axhausen F, Wolff S, Jünemann M, Krämer HH, Kampling H, Kruse J, Zara S, Pfeuffer S

Mult Scler Relat Disord. 2026 May 26; 111:107279. PMID: 42218888. Abstract